Concise answers when you need the essentials, with deeper clinical context and transparent source links when the decision needs more scrutiny.
Search by active ingredient or familiar medicine name.
Romosozumab is a monoclonal antibody that helps build bone and reduces bone breakdown. It is licensed for severe osteoporosis in postmenopausal women at high risk of fracture, under specialist supervision.
Ropeginterferon alfa-2b is a long-acting recombinant interferon that helps control abnormal blood-cell production. It is licensed as sole treatment for adults with polycythaemia vera without symptomatic enlargement of the spleen.
Ropinirole is a non-ergoline dopamine agonist used to improve movement symptoms in Parkinson’s disease. The selected prolonged-release product can be used alone or with levodopa.
Ropinirole hydrochloride is a non-ergoline dopamine agonist used for Parkinson’s disease. Selected immediate-release tablets are also licensed for moderate to severe idiopathic restless legs syndrome.
Ropivacaine hydrochloride is a long-acting amide local anaesthetic. It is administered by trained clinicians to numb nerves and manage acute pain, including pain during labour or after surgery.
Ropivacaine hydrochloride monohydrate is a long-acting local anaesthetic. It is given near nerves or into the epidural space to numb part of the body and manage pain during labour or after procedures.
Rotigotine is a non-ergot dopamine agonist supplied as a skin patch. This selected product is licensed to relieve moderate to severe idiopathic restless legs syndrome in adults.
Roxadustat is an oral HIF prolyl-hydroxylase inhibitor for symptomatic anaemia associated with chronic kidney disease in adults. It promotes red-cell production and improves iron availability; treatment is monitored with haemoglobin and other blood tests.
Rozanolixizumab is a monoclonal antibody that lowers circulating IgG antibodies. In the UK, it is licensed as an add-on to standard treatment for certain adults with generalised myasthenia gravis.
Rubidium chloride Rb-82 is a short-lived radioactive tracer used during specialist PET heart imaging. It shows blood flow through the heart muscle at rest or during medicine-induced stress; it does not treat heart disease.
Rufinamide is an anti-seizure treatment used alongside other treatments for seizures associated with Lennox-Gastaut syndrome. Selected products are licensed from 1 year of age and treatment should be started by an experienced paediatric or neurology specialist.
Rupatadine is a second-generation antihistamine used to relieve symptoms of allergic rhinitis and urticaria. Tablet and oral-solution products cover different age groups.
Rurioctocog alfa pegol is a recombinant, PEGylated factor VIII replacement. It is licensed to treat and prevent bleeding in people aged 12 years and over with haemophilia A. The selected eMC presentation is marked as discontinued.
Ruxolitinib phosphate is a targeted protein kinase inhibitor that blocks JAK1 and JAK2 signalling. In the UK, oral products are used for certain myeloproliferative blood cancers and for graft-versus-host disease that has not responded adequately to corticosteroids.